ETC
IDYA icon

Exchange Traded Concepts’s IDEAYA Biosciences IDYA Stock Holding History

Exchange Traded Concepts’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-6,659
Closed -$109K – 1455
2025
Q1 		$109K Buy
6,659
+2,112
+46% +$45K ﹤0.01% 1128
2024
Q4 		$117K Hold
4,547
– – ﹤0.01% 1123
2024
Q3 		$144K Sell
4,547
-304
-6% -$11.5K ﹤0.01% 1079
2024
Q2 		$170K Sell
4,851
-1,509
-24% -$59.8K ﹤0.01% 893
2024
Q1 		$279K Buy
6,360
+1,554
+32% +$66.8K 0.01% 834
2023
Q4 		$171K Buy
4,806
+1,219
+34% +$36.4K ﹤0.01% 810
2023
Q3 		$96.8K Sell
3,587
-2,063
-37% -$52.3K ﹤0.01% 908
2023
Q2 		$133K Buy
+5,650
New +$116K ﹤0.01% 880

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Exchange Traded Concepts's IDYA Position: Q2 2025 in Review

Exchange Traded Concepts sold out of IDEAYA Biosciences (IDYA) in Q2 2025, closing a stake of 6,659 shares — an estimated $109K sold.

Exchange Traded Concepts first reported a position in IDYA in Q2 2023 and held it in 8 quarters. The position peaked at $279K in Q1 2024. 204 funds tracked by Wall St. Rank hold IDYA as of Q2 2025.

  • Exchange Traded Concepts reported no remaining IDEAYA Biosciences position as of Q2 2025 after selling out during the quarter.
  • Exchange Traded Concepts sold 6,659 IDEAYA Biosciences shares in Q2 2025, an estimated $109K.
  • Exchange Traded Concepts first reported a position in IDEAYA Biosciences in Q2 2023 and held it in 8 quarters.
  • Exchange Traded Concepts's IDEAYA Biosciences position peaked at $279K in Q1 2024.
  • 204 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2025.

Based on Exchange Traded Concepts's 13F filing for Q2 2025, filed 10 Jul 2025.